[2-(1-methylcyclohexyl)oxy-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)-4-methylcyclohexa-1,5-diene-1-carboxylate
C24H38O4 — CID 123666193
Data last refreshed: (MolForge compound catalog, from PubChem)
About [2-(1-methylcyclohexyl)oxy-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)-4-methylcyclohexa-1,5-diene-1-carboxylate
[2-(1-methylcyclohexyl)oxy-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)-4-methylcyclohexa-1,5-diene-1-carboxylate (PubChem CID 123666193) has the molecular formula C24H38O4 and a molecular weight of 390.56 g/mol. Its IUPAC name is [2-(1-methylcyclohexyl)oxy-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)-4-methylcyclohexa-1,5-diene-1-carboxylate.
Molecular Properties
| Compound Name | [2-(1-methylcyclohexyl)oxy-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)-4-methylcyclohexa-1,5-diene-1-carboxylate |
|---|---|
| PubChem CID | 123666193 |
| Molecular Formula | C24H38O4 |
| Molecular Weight | 390.56 g/mol |
| Exact Mass | 390.28 |
| IUPAC Name | [2-(1-methylcyclohexyl)oxy-2-oxoethyl] 4-(3,3-dimethylpentan-2-yl)-4-methylcyclohexa-1,5-diene-1-carboxylate |
| SMILES | CCC(C)(C)C(C)C1(C)C=CC(C(=O)OCC(=O)OC2(C)CCCCC2)=CC1 |
| InChI | InChI=1S/C24H38O4/c1-7-22(3,4)18(2)23(5)15-11-19(12-16-23)21(26)27-17-20(25)28-24(6)13-9-8-10-14-24/h11-12,15,18H,7-10,13-14,16-17H2,1-6H3 |
| InChIKey | OYZBDIJOPVIWRY-UHFFFAOYSA-N |
| XLogP | 5.76 |
| TPSA | 52.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 390.56 |
| LogP ≤ 5 | 5.76 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 123666193 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.